Inventor
Lihong Sun
Inventor
Lexington, MA, US
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07DHeterocyclic compounds23%
A61KPreparations for medical, dental or toiletry purposes21%
C07CAcyclic or carbocyclic compounds12%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
C07BGeneral methods of organic chemistry6%
Y02ATechnologies for adaptation to climate change3%
B62DMotor vehicles1%
B65DContainers for storage or transport of articles or materials, e.g. bags, barrels, bottles, boxes, cans, cartons, crates, drums, jars, tanks, hoppers, forwarding containers1%
F25BRefrigeration machines, plants or systems1%
PatentTitleYear
10,926,938Insulating container, transportation device and transportation method202110,759,783Biaryl inhibitors of Bruton'S tyrosine kinase202010,273,234Compounds that are S1P modulating agents and/or ATX modulating agents201910,081,619Biaryl inhibitors of bruton's tyrosine kinase201810,030,016Heterocyclic compounds useful as PDK1 inhibitors201810,017,506ATX modulating agents20189,944,666Compounds that are S1P modulating agents and/or ATX modulating agents20189,873,693Methods of treatment using pyridinonyl PDK1 inhibitors20189,809,577'Biaryl inhibitors of Bruton\'s tyrosine kinase'20179,771,326'S1P and/or ATX modulating agents'20179,555,050'ATX modulating agents'20179,550,798'Compounds that are S1P modulating agents and/or ATX modulating agents'20179,546,165'Heterocyclic compounds useful as PDK1 inhibitors'20179,522,889'ATX modulating agents'20169,499,485'Compounds that are S1P modulating agents and/or ATX modulating agents'20168,778,977'Pyridinonyl PDK1 inhibitors'20147,691,865'Pyrazolopyridines and methods of making and using the same'20107,612,094'Tri-substituted heteroaryls and methods of making and using the same'20097,173,046'CD40:CD154 binding interrupter compounds and use thereof to treat immunological complications'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2010Based in Arlington, MA, US· patent location history
2009–2010Patents assigned to BIOGEN IDEC INC (2)· patent assignee history
2014–2018Patents assigned to SUNESIS PHARMACEUTICALS INC (4)· patent assignee history
2014–2017Patents assigned to GUCKIAN KEVIN (2)· patent assignee history
2014–2020Based in Lexington, MA, US· patent location history
2016–2020Patents assigned to BIOGEN MA INC (11)· patent assignee history
2017–2018Patents assigned to MILLENNIUM PHARM INC (3)· patent assignee history
2017Based in Cambridge, MA, US· patent location history
2021Based in Wuhan, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOGEN MA INC | 11 | 2016–2020 |
| SUNESIS PHARMACEUTICALS INC | 4 | 2014–2018 |
| MILLENNIUM PHARM INC | 3 | 2017–2018 |
| BIOGEN IDEC INC | 2 | 2009–2010 |
| GUCKIAN KEVIN | 2 | 2014–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Lexington, Massachusetts, US | 14 | 2014–2020 |
| Arlington, Massachusetts, US | 3 | 2007–2010 |
| Wuhan, CN | 1 | 2021 |
| Cambridge, Massachusetts, US | 1 | 2017 |